AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 179 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $405,000 | +45.2% | 8,523 | +10.4% | 0.15% | -55.8% |
| Q4 2018 | $279,000 | -62.8% | 7,723 | -44.2% | 0.34% | +13.4% |
| Q1 2018 | $751,000 | +0.4% | 13,844 | +10.6% | 0.30% | -18.1% |
| Q4 2017 | $748,000 | +11.1% | 12,516 | -9.6% | 0.36% | -47.2% |
| Q3 2017 | $673,000 | – | 13,844 | – | 0.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 244,783 | $1,718,000 | 0.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $32,959,000 | 0.69% |
| DCF Advisers, LLC | 192,065 | $1,348,000 | 0.55% |
| LEVIN CAPITAL STRATEGIES, L.P. | 817,377 | $5,738,000 | 0.54% |
| DAFNA Capital Management LLC | 289,040 | $2,029,000 | 0.51% |
| Rhenman & Partners Asset Management AB | 750,000 | $5,378,000 | 0.36% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,175,000 | 0.31% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,203,592 | $8,449,000 | 0.30% |
| AlphaCentric Advisors LLC | 137,000 | $962,000 | 0.28% |
| PFM Health Sciences, LP | 1,088,566 | $7,642,000 | 0.26% |